The Type dimension of Life Science Logistics segmentation distinguishes the physical handling and transport characteristics required by biopharmaceutical products. Temperature‑controlled logistics accounts for the majority of revenue, as vaccines, biologics, and cell therapies demand strict cold‑chain compliance (2‑8 °C, -20 °C, or -80 °C). Hazardous‑material logistics covers the regulated movement of cytotoxic drugs, radiopharmaceuticals, and genetically modified organisms, which adds compliance‑driven cost layers and specialized packaging. Bulk and bulk‑storage logistics focuses on large‑volume raw materials such as bulk reagents, media, and excipients, emphasizing warehouse capacity and inventory turnover. Specialty‑item logistics includes low‑volume, high‑value items like gene‑editing kits or rare antibodies, where traceability, security, and rapid delivery are critical. Each subtype contributes distinct cost structures and capacity requirements, collectively shaping the overall market size by dictating infrastructure investment, service pricing, and regulatory overhead within the Life Science Logistics market.